FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.706
-0.067 (-8.61%)
At close: Feb 21, 2025, 4:00 PM
0.658
-0.048 (-6.80%)
After-hours: Feb 21, 2025, 7:59 PM EST
FibroGen Employees
FibroGen had 486 employees as of December 31, 2023. The number of employees decreased by 106 or -17.91% compared to the previous year.
Employees
486
Change (1Y)
-106
Growth (1Y)
-17.91%
Revenue / Employee
$370,401
Profits / Employee
-$250,603
Market Cap
71.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
FGEN News
- 2 days ago - Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga
- 2 days ago - FibroGen sells China unit to AstraZeneca in deal worth $160 million - Reuters
- 2 days ago - FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million - GlobeNewsWire
- 2 months ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 3 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha